Singapore - English - HSA (Health Sciences Authority)

pharm-d singapore private limited - pasireotide diaspartate 0.75242mg eqv. pasireotide - injection, solution - 0.6 mg - pasireotide diaspartate 0.75242mg eqv. pasireotide 0.6 mg

Singapore - English - HSA (Health Sciences Authority)

pharm-d singapore private limited - pasireotide diaspartate 1.12863mg eqv. pasireotide - injection, solution - 0.9 mg - pasireotide diaspartate 1.12863mg eqv. pasireotide 0.9 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 300microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 600microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pasireotide diaspartate - solution for injection - 900microgram/1ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fta healthcare sdn. bhd. - pasireotide diaspartate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fta healthcare sdn. bhd. - pasireotide diaspartate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fta healthcare sdn. bhd. - pasireotide diaspartate -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pasireotide diaspartate 0.3762 mg/ml equivalent to pasireotide 0.3 mg/ml - solution for injection - 300 mcg/ml - active: pasireotide diaspartate 0.3762 mg/ml equivalent to pasireotide 0.3 mg/ml excipient: mannitol nitrogen sodium hydroxide tartaric acid water for injection - the treatment of adult patients with cushing's disease for whom surgery is not an option or for whom surgery has failed.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pasireotide diaspartate 0.7524 mg/ml equivalent to pasireotide 0.6 mg/ml - solution for injection - 600 mcg/ml - active: pasireotide diaspartate 0.7524 mg/ml equivalent to pasireotide 0.6 mg/ml excipient: mannitol nitrogen sodium hydroxide tartaric acid water for injection - the treatment of adult patients with cushing's disease for whom surgery is not an option or for whom surgery has failed.